Shares of RH were down 4.10% to $25.24 in pre-market trading on Tuesday after Buckingham Research cut its rating on the stock, saying the choppy recovery ahead raises liquidity concerns. The firm downgraded shares to “underperform” from “neutral” and reduced its price target to $22 from $34, implying 16% downside from current levels.